Your Location:Home > Products > API > Agomelatine

Agomelatine

Basic information

  • Product Name:Agomelatine
  • CasNo.:138112-76-2
  • MF:C15H17NO2
  • MW:243.305

Physical and Chemical Properties

  • Purity:99%
  • Boiling Point:107-109 °C
  • Packing:white solid
  • Throughput:
Inquiry

Product Details

CasNo: 138112-76-2

MF: C15H17NO2

Appearance: white solid

Wholesale Factory Supply High Purity Agomelatine 138112-76-2 with Cheapest Price

  • Molecular Formula:C15H17NO2
  • Molecular Weight:243.305
  • Appearance/Colour:white solid 
  • Melting Point:107-109 °C 
  • Boiling Point:478.8 °C at 760 mmHg 
  • PKA:16.17±0.46(Predicted) 
  • Flash Point:243.4 °C 
  • PSA:38.33000 
  • Density:1.109 g/cm3 
  • LogP:2.91790 

Agomelatine(Cas 138112-76-2) Usage

Description

Agomelatine is an atypical antidepressant used primarily to treat major depressive disorder and generalized anxiety disorder. It operates uniquely as both a melatonin receptor agonist (MT1 and MT2) and a serotonin 2C (5-HT2C) receptor antagonist. This dual action helps regulate circadian rhythms and improve sleep quality, which are often disrupted in depressive patients, without the typical side effects associated with SSRIs and SNRIs.

Uses

Agomelatine, developed by the French company Servier, is more metabolically stable than melatonin due to its naphthalene structure replacing the indole ring of melatonin. Its efficacy stems from its ability to stabilize circadian rhythms and exert antidepressant effects through these receptors, leading to improvements in both mood and sleep. Despite its benefits, agomelatine is associated with risks of liver toxicity, necessitating regular liver function tests. The drug is metabolized primarily by the hepatic cytochrome P450 enzyme CYP1A2, with minor contributions from CYP2C9 and CYP2C19, and its metabolites are inactive and excreted in the urine.

InChI:InChI=1/C11H14N4O2.CH4O3S/c1-5-2-9(16)7-3-8(14-15-11(12)13)10(17)4-6(5)7;1-5(2,3)4/h3-5,9,16H,2H2,1H3,(H4,12,13,15);1H3,(H,2,3,4)/b14-8-;

138112-76-2 Relevant articles

Simple and Efficient Process for the Large-Scale Preparation of Agomelatine: An Antidepressant Drug

Vujjini, Satish Kumar,Vyala, Sunitha,Badarla, Krishna Rao,Kandala, Sreenatha Charyulu,Bandichhor, Rakeshwar,Kagga, Mukkanti,Cherukupalli, Praveen

, p. 1864 - 1870 (2015)

A simple and efficient process for the l...

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

Christian de Bodinat, Béatrice Guardiola-Lemaitre, Elisabeth Mocaër, Pierre Renard, Carmen Muñoz & Mark J. Millan

, Nature Reviews Drug Discovery volume 9, pages628–642 (2010)

Agomelatine, the first melatonergic antidepressant, was designed to improve depressed states by resynchronizing perturbed biological rhythms. Its 'synergistic' agonist properties at melatonin receptors plus antagonist properties at 5-hydroxytryptamine 2C (5-HT2C) receptors account for its beneficial influence on depressed states.

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies

D Taylor, A Sparshatt, S Varma, O Olofinjana

, BMJ 2014; 348

Agomelatine was significantly more effective than placebo with an effect size (SMD) of 0.24 (95% confidence interval 0.12 to 0.35) and relative risk of response 1.25 (1.11 to 1.4). Compared with other antidepressants, agomelatine showed equal efficacy (SMD 0.00, −0.09 to 0.10). Significant heterogeneity was uncovered in most analyses, though risk of bias was low. Published studies were more likely than unpublished studies to have results that suggested advantages for agomelatine.

Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands

Depreux,Lesieur,Mansour,Morgan,Howell,Renard,Caignard,Pfeiffer,Delagrange,Guardiola,Yous,Demarque,Adam,Andrieux

, p. 3231 - 3239 (1994)

A series of N-naphthylethyl amide deriva...

138112-76-2 Upstream products

  • 139525-77-2
    139525-77-2

    2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride

  • 75-36-5
    75-36-5

    acetyl chloride

  • 138113-09-4
    138113-09-4

    2-(7-methoxynaphth-1-yl)ethylamine

  • 6836-22-2
    6836-22-2

    2-(7-methoxynaphthalen-1-yl)acetic acid

138112-76-2 Downstream products

  • 152302-45-9
    152302-45-9

    N-[2-(7-Hydroxy-1-naphthyl)ethyl]-acetamide

  • 166526-99-4
    166526-99-4

    N-[2-(7-methoxy-3-hydroxynaphth-1-yl)ethyl]-acetamide

  • 166527-00-0
    166527-00-0

    N-[2-(3,7-dihydroxy-1-naphthyl)ethyl]acetamide

  • 1096252-78-6
    1096252-78-6

    N-(2-{7-[(4-methoxybenzyl)amino]naphth-1-yl}ethyl)acetamide